Windtree Therapeutics Inc (NAS:WINT)
$ 0.2552 -0.0137 (-5.09%) Market Cap: 2.29 Mil Enterprise Value: 2.01 Mil PE Ratio: 0 PB Ratio: 0.14 GF Score: 22/100

Windtree Therapeutics Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript

Apr 04, 2022 / 03:00PM GMT
Release Date Price: $999 (+0.91%)
Robert Blum
Lytham Partners, LLC - Managing Partner

All right. Hello, everyone, and thank you all for joining us during the Lytham Partners Spring 2022 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners. And during this presentation, we welcome Windtree Therapeutics -- ticker symbol of WINT on the NASDAQ -- and the company's Chief Executive Officer, Craig Fraser. Today, I've asked Craig to run through the slide presentation, and we will then engage in a short fireside chat-like Q&A session.

Before I do turn it over to Craig, I want to remind everyone that the company is available for one-and-one meetings later this week. (Conference Instructions)

So with that said, let me turn the presentation over to Craig Fraser, Chief Executive Officer, Windtree Therapeutics. Craig, please proceed.

Craig Fraser
Windtree Therapeutics, Inc. - CEO & President

Thank you, Robert. I hope everybody is doing well and has a very productive conference. I'm going to share my slides very quickly here. And I've been looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot